Biotech

All Articles

8 months after a $213M fundraise, genetics editor Volume produces cuts

.After increasing $213 million in 2023-- some of the year's biggest exclusive biotech shots-- Volume...

BioMarin builds exec staff along with biotech veterinarians-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our summary of considerable management hirings, shootings a...

Biopharma Q2 VC struck highest degree given that '22, while M&ampA reduced

.Equity capital backing right into biopharma rose to $9.2 billion around 215 sell the 2nd one-fourth...

Bicara, Zenas find IPOs to press late-phase properties toward market

.Bicara Therapeutics as well as Zenas Biopharma have actually provided new incentive to the IPO mark...

Genentech to close cancer cells immunology investigation department

.Genentech will certainly close its own cancer cells immunology study department, and system head an...

Kezar falls sound tumor yet to prove its own truly worth in phase 1 trial

.Kezar Life Sciences is actually dropping its own dim phase 1 solid cyst drug as the biotech goes al...

Acelyrin goes down izokibep, lays off 3rd of workers

.Despite izokibep keeping its own newly found winning streak in the clinic, Acelyrin is no longer pa...

Rivus' stage 2 obesity-related heart failure test reaches endpoint

.Rivus Pharmaceuticals has plumped up the customers of its fat-busting, muscle-sparing medicine cand...

Ovid standstills preclinical work, IV course after soticlestat fail

.Ovid Rehab already revealed last month that it was trimming back its headcount as the business navi...

Eli Lilly opens up $700M nucleic acid R&ampD facility in Boston Seaport

.Eli Lilly has actually opened up a $700 million R&ampD facility in the Boston ma Port, enhancing it...